Daniel Gerlach: Starting the Lung Cancer Session at ASCO 2026
Daniel Gerlach / LinkedIn

Daniel Gerlach: Starting the Lung Cancer Session at ASCO 2026

Daniel Gerlach, Associate Scientific Director, Computational Biology Oncology at Boehringer Ingelheim, shared a post on LinkedIn:

“Happy ASCO26 opening day!

Lung Cancer session starts in 15 minutes, I’ll better get my spot – see you in Hall D2

Other articles featuring Daniel Gerlach on OncoDaily.